Hainan Poly Pharm. Co., Ltd

SZSE:300630.SZ

20.3 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q22015 Q1
Revenue 131.135306.327681.339518.194460.874373.166435.653575.088427.678367.926372.186513.587349.664273.392406.561380.362230.842170.839341.561256.663194.911156.959221.719151.461156.76993.955126.22168.5281.85348.23299.68245.20267.1435.98545.9645.96
Cost of Revenue 81.00974.208114.003184.558148.44104.662296.734125.269119.54375.415172.017117.88787.78251.168154.0173.22947.53225.26269.39650.31332.14222.91430.3630.72723.76216.50216.5568.5518.81711.38221.3769.40417.3199.57111.58611.586
Gross Profit 50.126232.119567.336333.636312.434268.504138.919449.819308.135292.511200.169395.7261.881222.225252.551307.132183.31145.577272.165206.35162.77134.046191.359120.734133.00777.452109.66559.9763.03636.8578.30635.79849.82126.41334.37434.374
Gross Profit Ratio 0.3820.7580.8330.6440.6780.720.3190.7820.720.7950.5380.770.7490.8130.6210.8070.7940.8520.7970.8040.8350.8540.8630.7970.8480.8240.8690.8750.770.7640.7860.7920.7420.7340.7480.748
Reseach & Development Expenses 56.28354.7437.83298.12270.20161.5184.8125.78175.79856.65925.21394.50259.39550.20825.7888.97752.21524.20871.31640.57549.84422.55855.03724.33836.50516.13899.3679.12718.114025.209011.42105.5995.599
General & Administrative Expenses 4.38135.425-19.9767.1826.22715.061-30.13865.0455.97812.717-44.92764.2643.17810.883-18.86523.2172.2115.901-8.01421.3052.6695.867-1.16914.056-10.54920.682-35.31617.178-6.92213.049-21.449.29717.0637.10711.40111.401
Selling & Marketing Expenses 131.0247.804280.28852.35476.18251.14179.5569.41253.98447.70773.43674.63146.1938.90444.9572.16329.96329.96771.8854.68842.1531.05744.99429.79140.61522.39624.92111.77121.84412.00229.9447.01618.629.14113.21913.219
SG&A 135.40283.229260.318119.53782.40866.202149.413134.45759.96360.42428.509138.89549.36949.78726.08695.3832.17335.86863.86675.99244.81836.92443.82543.84730.06643.078-10.39528.94914.92325.0518.50416.31335.68316.24823.45523.455
Other Expenses -3.5180.02826.986-0.1390.0680.019-0.6880.0720.0120.0180.488-1.0870.030.0150.0250.005-0.424-3.1680.806-0.2250.0030.053-0.0080.007-0.4320.468-1.3770.4780.4390.5527.1120.2731.088-0.00900
Operating Expenses 212.082135.737357.625165.558159.235121.024211.269229.714160.472105.733107.216207.594136.12497.73682.163168.82593.74159.396146.897113.936103.47960.106113.67668.95890.14543.34457.91230.05441.69525.5149.30516.73236.44216.58823.78223.782
Operating Income -173.15488.429120.626132.972138.528139.49-31.272171.623131.381167.7772.54163.435108.643123.478163.282128.82580.44485.255117.84588.97353.72472.98377.26153.46344.29934.39950.4431.49521.93111.52829.84818.96714.6739.84310.27810.278
Operating Income Ratio -1.320.2890.1770.2570.3010.374-0.0720.2980.3070.4560.1950.3180.3110.4520.4020.3390.3480.4990.3450.3470.2760.4650.3480.3530.2830.3660.40.460.2680.2390.2990.420.2190.2740.2240.224
Total Other Income Expenses Net -3.5180.02826.986-0.1390.0680.019-0.6880.0720.0120.0180.488-1.0870.030.0150.0250.005-0.424-3.1680.806-0.2250.0030.053-0.0080.007-0.4320.468-1.3770.4780.4390.5526.6560.2730.86-0.0090.5790.579
Income Before Tax -176.67288.456147.612132.832138.596139.509-31.96171.695131.394167.78873.027162.348108.674123.493163.307128.8380.0282.087118.65188.74853.72773.03677.25353.4743.86734.86749.06331.97322.3712.0836.50419.2415.5339.83410.85710.857
Income Before Tax Ratio -1.3470.2890.2170.2560.3010.374-0.0730.2990.3070.4560.1960.3160.3110.4520.4020.3390.3470.480.3470.3460.2760.4650.3480.3530.280.3710.3890.4670.2730.250.3660.4260.2310.2730.2360.236
Income Tax Expense -53.16921.766155.381-1.5227.0841.0762.8883.8425.566.0146.601-2.6934.7782.25340.8022.3611.6242.00623.5342.8023.6573.02116.9833.14.6653.76511.1812.6731.5021.7258.1980.3661.1891.5792.062.06
Net Income -123.50366.69-7.769134.355131.512138.433-34.848167.853125.833161.77826.427165.041103.896121.239122.505126.46978.39680.08195.11785.94650.0770.01560.2750.3739.20231.10337.88229.320.86810.35428.30718.87314.3438.2558.7978.797
Net Income Ratio -0.9420.218-0.0110.2590.2850.371-0.080.2920.2940.440.0710.3210.2970.4430.3010.3320.340.4690.2780.3350.2570.4460.2720.3330.250.3310.30.4280.2550.2150.2840.4180.2140.2290.1910.191
EPS -0.280.15-0.0180.310.30.32-0.080.390.290.370.060.370.290.240.280.290.180.180.220.20.120.170.140.120.0890.0740.0880.0750.050.0320.0910.0580.0470.0260.0280.028
EPS Diluted -0.280.14-0.0170.280.240.32-0.080.390.290.370.060.370.260.240.280.290.180.180.220.20.120.170.140.120.0890.0740.0880.070.050.0320.0910.0520.0470.0260.0280.028
EBITDA -156.83595.229238.001169.206160.47149.175-72.176219.893152.672188.028123.059165.248123.234124.489163.922145.56386.85386.282125.24894.58656.37173.9479.76952.81744.67134.10854.05329.59923.64611.34139.32519.213.3799.82513.48513.485
EBITDA Ratio -1.1960.3110.3490.3270.3480.4-0.1660.3820.3570.5110.3310.3220.3520.4550.4030.3830.3760.5050.3670.3690.2890.4710.360.3490.2850.3630.4280.4320.2890.2350.3950.4250.1990.2730.2930.293